Growth Metrics

Armata Pharmaceuticals (ARMP) Other Non Operating Income (2016 - 2026)

Quarterly results put Other Non Operating Income at -$101.1 million for Q1 2026, down 2044.23% from a year ago — trailing twelve months through Mar 2026 was -$119.8 million (down 314.52% YoY), and the annual figure for FY2025 was $388000.0, down 98.35%.

Armata Pharmaceuticals has reported Other Non Operating Income over the past 14 years, most recently at -$101.1 million for Q1 2026.

  • Other Non Operating Income reached -$101.1 million in Q1 2026 per ARMP's latest filing, down from $131000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $23.4 million in Q2 2024 and bottomed at -$101.1 million in Q1 2026.
  • Median Other Non Operating Income over the past 5 years was $9000.0 (2022), compared with a mean of -$6.0 million.
  • Peak annual rise in Other Non Operating Income hit 120620.0% in 2023, while the deepest fall reached 314500.0% in 2023.
  • Over 5 years, Other Non Operating Income stood at $14000.0 in 2022, then plummeted by 168671.43% to -$23.6 million in 2023, then surged by 197.26% to $23.0 million in 2024, then crashed by 99.43% to $131000.0 in 2025, then crashed by 77275.57% to -$101.1 million in 2026.
  • Business Quant data shows Other Non Operating Income for ARMP at -$101.1 million in Q1 2026, $131000.0 in Q4 2025, and -$18.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -101.10 Mn
Dec 31, 2025 131,000.00
Sep 30, 2025 -18.90 Mn
Jun 30, 2025 108,000.00
Mar 31, 2025 5.20 Mn
Dec 31, 2024 22.95 Mn
Sep 30, 2024 4.28 Mn
Jun 30, 2024 23.40 Mn
Mar 31, 2024 -13.03 Mn
Dec 31, 2023 -23.60 Mn
Sep 30, 2023 -3.86 Mn
Jun 30, 2023 6.04 Mn
Mar 31, 2023 -3.14 Mn
Dec 31, 2022 14,000.00
Sep 30, 2022 9,000.00
Jun 30, 2022 5,000.00
Mar 31, 2022 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 724,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 -60,000.00
Dec 31, 2020 -171,000.00
Sep 30, 2020 -146,000.00
Jun 30, 2020 -120,000.00
Mar 31, 2020 -157,000.00
Sep 30, 2019 -178,000.00
Jun 30, 2019 1.16 Mn
Mar 31, 2019 -40,000.00
Dec 31, 2018 2.46 Mn
Sep 30, 2018 -342,000.00
Jun 30, 2018 -324,000.00
Mar 31, 2018 -79,000.00
Dec 31, 2017 13,000.00
Sep 30, 2017 4,000.00
Jun 30, 2017 1.92 Mn
Mar 31, 2017 114,000.00
Dec 31, 2016 1.81 Mn
Sep 30, 2016 1.03 Mn
Jun 30, 2016 -35,000.00